Stock Rating Downgrade
In the last week the Value Trend Rating for Lifecore Biomedical Inc (NASDAQ: LFCR) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential.
Recent Price Action
Lifecore Biomedical Inc (NASDAQ: LFCR) stock closed at $5.91 on 2/7/25 after a decline of -3.6%. However, unusually low trading volume at 52% of normal accompanied the decline. The stock has declined -3.1% during the last week but has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Lifecore Biomedical has a current Value Trend Rating of D (Negative). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Lifecore Biomedical has a very low Appreciation Score of 1 but a good Power Rating of 81, producing the Negative Value Trend Rating.
Be the first to comment